Health In Tech (HIT) investor relations material

Opening remarks and agenda

• Meeting opened at 10:05 a.m. ET on Nov. 10, 2026; stockholders could vote and submit questions through the online portal.

• Sept. 18, 2026, was the record date; 65,300,790 common shares were outstanding: 53,600,790 Class A and 11,700,000 Class B.

• Proxies submitted before the Oct. 28 supplement were disregarded; only post-supplement submissions and votes cast at the meeting counted toward voting and quorum.

Board and executive committee updates

• Tim Johnson, Julia Qian, William Howard, Timothy Hayes, and Tim Cortes were elected to serve until the 2027 AGM and until successors are elected and qualified, subject to earlier departure.

Shareholder proposals

• Proposed increasing authorized capital from 220 million to 720 million shares: 650 million Class A, 50 million Class B, and 20 million preferred shares.

• SEPA proposal sought approval for issuance of over 20% of outstanding Class A shares under the Aug. 12, 2026, agreement with YA II PN, Ltd., including shares on convertible-note conversion.

• Amended 2024 Plan proposal sought to raise authorized Class A award shares from 10,677,849 to 30,677,849 and the aggregate incentive stock option limit to 13 million; it replaced the original proposal.

• Auditor proposal sought ratification of MaloneBailey, LLP for the fiscal year ending Dec. 31, 2026.